BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28935177)

  • 21. Autophagy facilitates lung adenocarcinoma resistance to cisplatin treatment by activation of AMPK/mTOR signaling pathway.
    Wu T; Wang MC; Jing L; Liu ZY; Guo H; Liu Y; Bai YY; Cheng YZ; Nan KJ; Liang X
    Drug Des Devel Ther; 2015; 9():6421-31. PubMed ID: 26715839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-326 reverses chemoresistance in human lung adenocarcinoma cells by targeting specificity protein 1.
    Li J; Li S; Chen Z; Wang J; Chen Y; Xu Z; Jin M; Yu W
    Tumour Biol; 2016 Oct; 37(10):13287-13294. PubMed ID: 27460077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET.
    Chen QY; Jiao DM; Wang J; Hu H; Tang X; Chen J; Mou H; Lu W
    Oncotarget; 2016 Apr; 7(17):24510-26. PubMed ID: 27014910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Downregulation of HIF-2α Reverse the Chemotherapy Resistance of Lung Adenocarcinoma A549 Cells to Cisplatin.
    Gao ZJ; Yuan WD; Yuan JQ; Yuan K; Wang Y
    Med Sci Monit; 2018 Feb; 24():1104-1111. PubMed ID: 29469087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HtrA1 downregulation induces cisplatin resistance in lung adenocarcinoma by promoting cancer stem cell-like properties.
    Xu Y; Jiang Z; Zhang Z; Sun N; Zhang M; Xie J; Li T; Hou Y; Wu D
    J Cell Biochem; 2014 Jun; 115(6):1112-21. PubMed ID: 24356998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. β-Catenin signaling pathway regulates cisplatin resistance in lung adenocarcinoma cells by upregulating Bcl-xl.
    Zhang J; Liu J; Li H; Wang J
    Mol Med Rep; 2016 Mar; 13(3):2543-51. PubMed ID: 26860078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reversal of galectin-1 gene silencing on resistance to cisplatin in human lung adenocarcinoma A549 cells.
    Zhang L; Liu X; Tang Z; Li X; Wang G
    Biomed Pharmacother; 2016 Oct; 83():265-270. PubMed ID: 27392028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-107 regulates cisplatin chemosensitivity of A549 non small cell lung cancer cell line by targeting cyclin dependent kinase 8.
    Zhang Z; Zhang L; Yin ZY; Fan XL; Hu B; Wang LQ; Zhang D
    Int J Clin Exp Pathol; 2014; 7(10):7236-41. PubMed ID: 25400821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. lncRNA RP11-838N2.3 Promoted Cisplatin Resistance in Lung Adenocarcinoma.
    Chen J; Jiang F; Hu L; Zhang F; Wang J; Huang K; Wang Y
    Biomed Res Int; 2020; 2020():2806042. PubMed ID: 32626737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CXCR4 promotes cisplatin-resistance of non-small cell lung cancer in a CYP1B1-dependent manner.
    Xie S; Tu Z; Xiong J; Kang G; Zhao L; Hu W; Tan H; Tembo KM; Ding Q; Deng X; Huang J; Zhang Q
    Oncol Rep; 2017 Feb; 37(2):921-928. PubMed ID: 27922681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. sCLU regulates cisplatin chemosensitivity of lung cancer cells in vivo.
    Ma G; Cai H; Gao L; Wang M; Wang H
    World J Surg Oncol; 2015 Feb; 13():80. PubMed ID: 25884382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Knockdown of long non-coding RNA KCNQ1OT1 depressed chemoresistance to paclitaxel in lung adenocarcinoma.
    Ren K; Xu R; Huang J; Zhao J; Shi W
    Cancer Chemother Pharmacol; 2017 Aug; 80(2):243-250. PubMed ID: 28600629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bisdemethoxycurcumin sensitizes cisplatin-resistant lung cancer cells to chemotherapy by inhibition of CA916798 and PI3K/AKT signaling.
    Wang HJ; Yang ZX; Dai XT; Chen YF; Yang HP; Zhou XD
    Apoptosis; 2017 Sep; 22(9):1157-1168. PubMed ID: 28677094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LncRNA XIST promotes human lung adenocarcinoma cells to cisplatin resistance via let-7i/BAG-1 axis.
    Sun J; Pan LM; Chen LB; Wang Y
    Cell Cycle; 2017; 16(21):2100-2107. PubMed ID: 28961027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decrease in paracellular permeability and chemosensitivity to doxorubicin by claudin-1 in spheroid culture models of human lung adenocarcinoma A549 cells.
    Akizuki R; Maruhashi R; Eguchi H; Kitabatake K; Tsukimoto M; Furuta T; Matsunaga T; Endo S; Ikari A
    Biochim Biophys Acta Mol Cell Res; 2018 May; 1865(5):769-780. PubMed ID: 29524521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dickkopf-3 (Dkk3) induces apoptosis in cisplatin-resistant lung adenocarcinoma cells via the Wnt/β-catenin pathway.
    Wang Z; Ma LJ; Kang Y; Li X; Zhang XJ
    Oncol Rep; 2015 Mar; 33(3):1097-106. PubMed ID: 25573172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic Significance of microRNA-7 and its Roles in the Regulation of Cisplatin Resistance in Lung Adenocarcinoma.
    Cheng MW; Shen ZT; Hu GY; Luo LG
    Cell Physiol Biochem; 2017; 42(2):660-672. PubMed ID: 28618418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of livin expression suppresses cell proliferation and enhances chemosensitivity to cisplatin in human lung adenocarcinoma cells.
    Zhuang L; Shen LD; Li K; Yang RX; Zhang QY; Chen Y; Gao CL; Dong C; Bi Q; Tao JN; Wang XN; Tian Q
    Mol Med Rep; 2015 Jul; 12(1):547-52. PubMed ID: 25695324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Curcumin downregulates p38 MAPK-dependent X-ray repair cross-complement group 1 (XRCC1) expression to enhance cisplatin-induced cytotoxicity in human lung cancer cells.
    Tung CL; Jian YJ; Chen JC; Wang TJ; Chen WC; Zheng HY; Chang PY; Liao KS; Lin YW
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun; 389(6):657-66. PubMed ID: 27026405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long intergenic non-coding RNA 00152 promotes lung adenocarcinoma proliferation via interacting with EZH2 and repressing IL24 expression.
    Chen QN; Chen X; Chen ZY; Nie FQ; Wei CC; Ma HW; Wan L; Yan S; Ren SN; Wang ZX
    Mol Cancer; 2017 Jan; 16(1):17. PubMed ID: 28109288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.